AstraZeneca has partnered with Taiwan’s National Research Program for Biopharmaceuticals (NRPB) in order to support academic research proposals using 'open innovation' as a catalyst for accelerating drug discovery. The project will ...
US-based iCeutica announced that its partner Iroko Pharmaceuticals has received the US Food and Drug Administration (FDA) approval to market ZORVOLEX (diclofenac) capsules, a non-steroidal anti-inflammatory drug (NSAID) that utilizes ...
Medical device company Varian Medical Systems has obtained 510(k) approval from the US Food and Drug Administration for RapidPlan, a radiotherapy treatment planning tool designed to enhance quality, consistency, and efficiency in ...
Surefire Medical, a developer of infusion systems for the interventional radiology and interventional oncology markets, has introduced Surefire Infusion System mT, designed to treat vessels as small as 2–3.5mm in interventional ...
Epsilon Imaging, a provider of workflow enhancing solutions for cardiology, has introduced EchoInsight visualization and analysis platform, a new application for right ventricle (RV) assessment. The EchoInsight visualization and analysis ...
AstraZeneca's global biologics research and development division MedImmune will acquire Spirogen, a biotech firm focused on antibody-drug conjugate technology for use in oncology. Spirogen's complete shares will be purchased by MedImmune ...
Tags: biologics research, AstraZeneca
Boehringer Ingelheim has submitted a marketing authorisation application to the European Medicines Agency (EMA) for the approval of its oral triple angiokinase inhibitor nintedanib. Nintedanib to be used in combination with docetaxel is ...
Tags: Boehringer Ingelheim, Lung Cancer
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC) and Swiss biopharmaceutical firm Debiopharm Group (Debiopharm) have signed an exclusive research collaboration to develop oral small molecules ...
Tags: Cancer Drugs, Medicine
US-based clinical stage biopharmaceutical firm Heat Biologics has filed an investigational new drug application (NDA) with the US Food and Drug Administration (FDA) for its second product candidate, HS-410, which will be evaluated in ...
US-based biopharmaceutical company Galena Biopharma has launched the Abstral (fentanyl) sublingual tablets in the US for the treatment of breakthrough cancer pain. The sublingual (under the tongue) fentanyl tablet has been designed for ...
Tags: Sublingual Tablets, Medicine
US-based biotechnology company X-Chem and UK-based pharmaceutical company AstraZeneca have entered into an expanded global drug discovery collaboration that covers all of AstraZeneca’s therapeutic areas and multiple target classes. ...
Tags: Drug, pharmaceutical
Nucletron, an Elekta Company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for Esteya electronic brachytherapy system, a new approach for high precision skin cancer treatment. Depending on a small, high dose ...
The US Patent & Trademark Office (USPTO) has issued a notice of allowance for Elorac's patent application regarding novel acne therapy. The US patent is entitled "Method and Composition for Treating Nodulocystic and Conglobate Acne ...
Tags: Acne Therapy, Medicine
US-based biopharmaceutical company NovaRx will present the results from the Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer at the European Society for Medical Oncology (ESMO) ...
Tags: Novarx, Therapeutic Vaccine Trial
Medical imaging technology company Toshiba America Medical Systems has announced that it will launch its Aquilion large bore CT system at American Society of Radiation Oncology annual meeting in Atlanta. The US Food and Drug ...